Abacavir and Peritonitis - a phase IV clinical study of FDA data

Summary:

Peritonitis is reported as a side effect among people who take Abacavir (abacavir sulfate), especially for people who are male, 40-49 old, have been taking the drug for 1 - 2 years also take Lamivudine, and have Hyperuricaemia.

The phase IV clinical study analyzes which people have Peritonitis when taking Abacavir. It is created by eHealthMe based on reports of 8,281 people who have side effects when taking Abacavir from the FDA, and is updated regularly.

What is Abacavir?

Abacavir has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 8,306 Abacavir users. Check the latest studies of Abacavir.

What is Peritonitis?

Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs) is found to be associated with 1,062 drugs and 1,569 conditions by eHealthMe. Check the latest studies of Peritonitis.

On Jul, 15, 2026

8,281 people reported to have side effects when taking Abacavir.
Among them, 16 people (0.19%) have Peritonitis.

Among these 16 people:

How long have people been on Abacavir when they have Peritonitis? *

What is the gender of people who have Peritonitis when taking Abacavir? *

female: 9.09 %
male: 90.91 %

What is the age of people who have Peritonitis when taking Abacavir? *

What are other drugs people take besides Abacavir? *

What are other side effects people have besides Peritonitis? *

Diarrhea: 6 people, 37.50%
Fever: 5 people, 31.25%
Anaemia (lack of blood): 5 people, 31.25%
Pneumonia: 4 people, 25.00%
Histoplasmosis (infection caused by breathing in spores of a fungus): 4 people, 25.00%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 4 people, 25.00%
High Blood Pressure: 3 people, 18.75%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 18.75%
White Blood Cell Count Decreased: 3 people, 18.75%
Acute Kidney Failure: 3 people, 18.75%

What are the existing conditions these people have? *

Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 18.75%
Mycobacterial Infection: 2 people, 12.50%
Gastric Ulcer (stomach ulcer): 2 people, 12.50%
Dehydration (dryness resulting from the removal of water): 2 people, 12.50%
Anaemia (lack of blood): 2 people, 12.50%
Oesophageal Candidiasis (fungal infection of oesophagus): 1 person, 6.25%
High Blood Pressure: 1 person, 6.25%
Hepatitis C: 1 person, 6.25%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 1 person, 6.25%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Abacavir and have Peritonitis?

- Check whether Peritonitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abacavir:

Abacavir (8,306 reports)

Peritonitis treatments and more:

Peritonitis (27,277 reports)

Browse all side effects of Abacavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Peritonitis:

Peritonitis (1,062 drugs)

Browse all the conditions that are associated with Peritonitis:

Peritonitis (1,569 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abacavir sulfate (the active ingredients of Abacavir) and Abacavir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.